RNA Sequencing Solution for Oncology Research

In the research of diseases such as cancer, it is not enough to know whether a gene is mutated or normal. It is also important to understand whether and how the gene is expressed. Transcriptome analysis of cancer samples is becoming increasingly important for understanding how changes in the expression of genetic variants lead to cancer and other diseases. The analysis of differential RNA expression provides researchers with a deeper understanding of the biological pathways and molecular mechanisms that regulate cell fate, development, and disease progression.

Accelerate Research and Practice in Cancer Research

Monitoring changes in gene expression is essential for studying tumor biology and gaining insights into molecular mechanisms underlying cancer progression. Common sequencing approaches include RNA-seq, small RNA sequencing, lncRNA sequencing, circRNA sequencing, targeted RNA sequencing, exosomal RNA sequencing, and degradome sequencing. These transcriptome-level analyses support in-depth exploration of gene regulation, non-coding RNA functions, and RNA processing events in tumor samples.

CD Genomics offers a comprehensive cancer research solution based on advanced next-generation sequencing (NGS) and long-read sequencing platforms. We provide end-to-end services, including high-quality nucleic acid extraction from various sample types, and utilize Illumina NGS, PacBio SMRT sequencing, and Oxford Nanopore direct RNA sequencing to deliver accurate transcriptomic data. Our bioinformatics pipelines ensure in-depth analysis, and all results are delivered with customized reports to support your research objectives.

Our advantages
An abundance of sample handling experience
Enrichment and extraction of low-abundance transcripts
Multiple sequencing platforms to choose from
High accuracy of sequencing results
Comprehensive bioinformatics analysis and customized analysis

The issues that can be addressed with our RNA sequencing services
Differential cancer gene expression analysis
Cancer biomarker discovery and identification
Cancer heterogeneity and evolution research
Cancer drug resistance research
Cancer microenvironment and immunotherapy research
Neoantigen research
Drug research and development

Note: Our services are for research use only, not for disease diagnosis and treatment.

What can we do?

Sample types: various sample types, such as normal/tumor tissues, biological fluids, cfRNA
Data delivery: identification, quantitation, differential expression analysis, and other bioinformatics analyses

Service Workflow

Sequencing Platforms

Bioinformatics Analysis Contents

Comprehensive Solutions to Accelerate Your Oncology Research

CD Genomics has a professional technical team and bio-analysis team, and has more than ten years of project experience in the sequencing field. We have a mature technical route, provide accurate and reliable data and deliver results that meet your requirements. We are committed to providing efficient, cost-effective, and high-quality sequencing services to help your research in oncology fields.